nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—AR—duct of salivary gland—head and neck cancer	0.107	0.496	CbGeAlD
Levonorgestrel—SRD5A1—head—head and neck cancer	0.00984	0.0455	CbGeAlD
Levonorgestrel—Application site reaction—Fluorouracil—head and neck cancer	0.00944	0.0221	CcSEcCtD
Levonorgestrel—Breast cancer—Docetaxel—head and neck cancer	0.00876	0.0205	CcSEcCtD
Levonorgestrel—SHBG—neck—head and neck cancer	0.00848	0.0393	CbGeAlD
Levonorgestrel—Numbness—Vinblastine—head and neck cancer	0.00814	0.019	CcSEcCtD
Levonorgestrel—Sensory loss—Vinblastine—head and neck cancer	0.00779	0.0182	CcSEcCtD
Levonorgestrel—Tenderness—Hydroxyurea—head and neck cancer	0.00705	0.0165	CcSEcCtD
Levonorgestrel—Amenorrhoea—Hydroxyurea—head and neck cancer	0.007	0.0164	CcSEcCtD
Levonorgestrel—Neoplasm—Vinblastine—head and neck cancer	0.0061	0.0143	CcSEcCtD
Levonorgestrel—SHBG—connective tissue—head and neck cancer	0.00608	0.0281	CbGeAlD
Levonorgestrel—ESR1—neck—head and neck cancer	0.00598	0.0277	CbGeAlD
Levonorgestrel—Menstruation irregular—Docetaxel—head and neck cancer	0.00577	0.0135	CcSEcCtD
Levonorgestrel—Neoplasm—Hydroxyurea—head and neck cancer	0.00556	0.013	CcSEcCtD
Levonorgestrel—PGR—connective tissue—head and neck cancer	0.00548	0.0254	CbGeAlD
Levonorgestrel—Haemorrhoids—Docetaxel—head and neck cancer	0.00544	0.0127	CcSEcCtD
Levonorgestrel—Numbness—Fluorouracil—head and neck cancer	0.00534	0.0125	CcSEcCtD
Levonorgestrel—Polyp—Docetaxel—head and neck cancer	0.00525	0.0123	CcSEcCtD
Levonorgestrel—PGR—epithelium—head and neck cancer	0.0052	0.0241	CbGeAlD
Levonorgestrel—Sensory loss—Fluorouracil—head and neck cancer	0.00511	0.012	CcSEcCtD
Levonorgestrel—Tenderness—Fluorouracil—head and neck cancer	0.00508	0.0119	CcSEcCtD
Levonorgestrel—CYP19A1—connective tissue—head and neck cancer	0.00493	0.0228	CbGeAlD
Levonorgestrel—Herpes simplex—Fluorouracil—head and neck cancer	0.00481	0.0112	CcSEcCtD
Levonorgestrel—Cyst—Docetaxel—head and neck cancer	0.00478	0.0112	CcSEcCtD
Levonorgestrel—Redness—Docetaxel—head and neck cancer	0.00474	0.0111	CcSEcCtD
Levonorgestrel—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00464	0.0109	CcSEcCtD
Levonorgestrel—Dermatitis contact—Fluorouracil—head and neck cancer	0.00438	0.0102	CcSEcCtD
Levonorgestrel—AR—connective tissue—head and neck cancer	0.00436	0.0202	CbGeAlD
Levonorgestrel—ESR1—connective tissue—head and neck cancer	0.00428	0.0198	CbGeAlD
Levonorgestrel—AR—epithelium—head and neck cancer	0.00414	0.0192	CbGeAlD
Levonorgestrel—Otitis media—Docetaxel—head and neck cancer	0.00411	0.0096	CcSEcCtD
Levonorgestrel—ESR1—epithelium—head and neck cancer	0.00407	0.0188	CbGeAlD
Levonorgestrel—SHBG—thyroid gland—head and neck cancer	0.00404	0.0187	CbGeAlD
Levonorgestrel—Breast disorder—Hydroxyurea—head and neck cancer	0.00404	0.00944	CcSEcCtD
Levonorgestrel—PGR—lymphoid tissue—head and neck cancer	0.00401	0.0185	CbGeAlD
Levonorgestrel—Depression—Vinblastine—head and neck cancer	0.00376	0.0088	CcSEcCtD
Levonorgestrel—PGR—thyroid gland—head and neck cancer	0.00364	0.0168	CbGeAlD
Levonorgestrel—Amenorrhoea—Docetaxel—head and neck cancer	0.00364	0.00851	CcSEcCtD
Levonorgestrel—Dysuria—Hydroxyurea—head and neck cancer	0.00361	0.00844	CcSEcCtD
Levonorgestrel—Weight increased—Hydroxyurea—head and neck cancer	0.00351	0.00822	CcSEcCtD
Levonorgestrel—Infestation NOS—Hydroxyurea—head and neck cancer	0.00344	0.00805	CcSEcCtD
Levonorgestrel—Infestation—Hydroxyurea—head and neck cancer	0.00344	0.00805	CcSEcCtD
Levonorgestrel—Haemoglobin—Vinblastine—head and neck cancer	0.00341	0.00797	CcSEcCtD
Levonorgestrel—Haemorrhage—Vinblastine—head and neck cancer	0.00339	0.00793	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Vinblastine—head and neck cancer	0.00337	0.00789	CcSEcCtD
Levonorgestrel—Pharyngitis—Vinblastine—head and neck cancer	0.00336	0.00787	CcSEcCtD
Levonorgestrel—CYP19A1—thyroid gland—head and neck cancer	0.00327	0.0152	CbGeAlD
Levonorgestrel—PGR—head—head and neck cancer	0.00323	0.0149	CbGeAlD
Levonorgestrel—AR—lymphoid tissue—head and neck cancer	0.00319	0.0148	CbGeAlD
Levonorgestrel—ESR1—lymphoid tissue—head and neck cancer	0.00313	0.0145	CbGeAlD
Levonorgestrel—Haemoglobin—Hydroxyurea—head and neck cancer	0.00311	0.00726	CcSEcCtD
Levonorgestrel—Influenza like illness—Docetaxel—head and neck cancer	0.0031	0.00726	CcSEcCtD
Levonorgestrel—Haemorrhage—Hydroxyurea—head and neck cancer	0.00309	0.00723	CcSEcCtD
Levonorgestrel—Candida infection—Docetaxel—head and neck cancer	0.00305	0.00714	CcSEcCtD
Levonorgestrel—Fluid retention—Docetaxel—head and neck cancer	0.00303	0.0071	CcSEcCtD
Levonorgestrel—Alopecia—Vinblastine—head and neck cancer	0.00299	0.007	CcSEcCtD
Levonorgestrel—Dry skin—Fluorouracil—head and neck cancer	0.00295	0.00689	CcSEcCtD
Levonorgestrel—CYP19A1—head—head and neck cancer	0.0029	0.0134	CbGeAlD
Levonorgestrel—AR—thyroid gland—head and neck cancer	0.0029	0.0134	CbGeAlD
Levonorgestrel—Neoplasm—Docetaxel—head and neck cancer	0.00289	0.00676	CcSEcCtD
Levonorgestrel—Lightheadedness—Docetaxel—head and neck cancer	0.00286	0.00669	CcSEcCtD
Levonorgestrel—ESR1—thyroid gland—head and neck cancer	0.00285	0.0132	CbGeAlD
Levonorgestrel—Alopecia—Hydroxyurea—head and neck cancer	0.00273	0.00639	CcSEcCtD
Levonorgestrel—Anaemia—Vinblastine—head and neck cancer	0.00273	0.00638	CcSEcCtD
Levonorgestrel—Erythema—Hydroxyurea—head and neck cancer	0.00269	0.00629	CcSEcCtD
Levonorgestrel—Vertigo—Vinblastine—head and neck cancer	0.00265	0.0062	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00258	0.00604	CcSEcCtD
Levonorgestrel—AR—head—head and neck cancer	0.00257	0.0119	CbGeAlD
Levonorgestrel—Hypertension—Vinblastine—head and neck cancer	0.00255	0.00596	CcSEcCtD
Levonorgestrel—ESR1—head—head and neck cancer	0.00252	0.0117	CbGeAlD
Levonorgestrel—Pneumonia—Fluorouracil—head and neck cancer	0.00249	0.00583	CcSEcCtD
Levonorgestrel—Anaemia—Hydroxyurea—head and neck cancer	0.00249	0.00582	CcSEcCtD
Levonorgestrel—Discomfort—Vinblastine—head and neck cancer	0.00248	0.0058	CcSEcCtD
Levonorgestrel—Infestation NOS—Fluorouracil—head and neck cancer	0.00248	0.0058	CcSEcCtD
Levonorgestrel—Infestation—Fluorouracil—head and neck cancer	0.00248	0.0058	CcSEcCtD
Levonorgestrel—Urinary tract infection—Fluorouracil—head and neck cancer	0.00241	0.00563	CcSEcCtD
Levonorgestrel—Sinusitis—Fluorouracil—head and neck cancer	0.00232	0.00544	CcSEcCtD
Levonorgestrel—Pain in extremity—Docetaxel—head and neck cancer	0.00232	0.00543	CcSEcCtD
Levonorgestrel—Anorexia—Vinblastine—head and neck cancer	0.00229	0.00537	CcSEcCtD
Levonorgestrel—Migraine—Docetaxel—head and neck cancer	0.00228	0.00534	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00227	0.00532	CcSEcCtD
Levonorgestrel—Discomfort—Hydroxyurea—head and neck cancer	0.00226	0.00529	CcSEcCtD
Levonorgestrel—PGR—lymph node—head and neck cancer	0.00226	0.0105	CbGeAlD
Levonorgestrel—Haemoglobin—Fluorouracil—head and neck cancer	0.00224	0.00523	CcSEcCtD
Levonorgestrel—Rhinitis—Fluorouracil—head and neck cancer	0.00223	0.00522	CcSEcCtD
Levonorgestrel—Haemorrhage—Fluorouracil—head and neck cancer	0.00222	0.0052	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00221	0.00518	CcSEcCtD
Levonorgestrel—Pharyngitis—Fluorouracil—head and neck cancer	0.00221	0.00516	CcSEcCtD
Levonorgestrel—Oedema—Hydroxyurea—head and neck cancer	0.0022	0.00513	CcSEcCtD
Levonorgestrel—Infection—Hydroxyurea—head and neck cancer	0.00218	0.0051	CcSEcCtD
Levonorgestrel—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00215	0.00504	CcSEcCtD
Levonorgestrel—Skin disorder—Hydroxyurea—head and neck cancer	0.00213	0.00499	CcSEcCtD
Levonorgestrel—Dry skin—Docetaxel—head and neck cancer	0.00213	0.00498	CcSEcCtD
Levonorgestrel—Breast disorder—Docetaxel—head and neck cancer	0.0021	0.0049	CcSEcCtD
Levonorgestrel—Anorexia—Hydroxyurea—head and neck cancer	0.00209	0.00489	CcSEcCtD
Levonorgestrel—Decreased appetite—Vinblastine—head and neck cancer	0.00209	0.00489	CcSEcCtD
Levonorgestrel—Pain—Vinblastine—head and neck cancer	0.00206	0.00481	CcSEcCtD
Levonorgestrel—Constipation—Vinblastine—head and neck cancer	0.00206	0.00481	CcSEcCtD
Levonorgestrel—CYP19A1—lymph node—head and neck cancer	0.00203	0.00941	CbGeAlD
Levonorgestrel—Arrhythmia—Fluorouracil—head and neck cancer	0.00199	0.00465	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00197	0.0046	CcSEcCtD
Levonorgestrel—Alopecia—Fluorouracil—head and neck cancer	0.00197	0.0046	CcSEcCtD
Levonorgestrel—Dyspnoea—Hydroxyurea—head and neck cancer	0.00196	0.00458	CcSEcCtD
Levonorgestrel—Somnolence—Hydroxyurea—head and neck cancer	0.00195	0.00456	CcSEcCtD
Levonorgestrel—Erythema—Fluorouracil—head and neck cancer	0.00194	0.00453	CcSEcCtD
Levonorgestrel—Dyspepsia—Hydroxyurea—head and neck cancer	0.00193	0.00452	CcSEcCtD
Levonorgestrel—Decreased appetite—Hydroxyurea—head and neck cancer	0.00191	0.00446	CcSEcCtD
Levonorgestrel—Abdominal pain—Vinblastine—head and neck cancer	0.0019	0.00445	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0019	0.00443	CcSEcCtD
Levonorgestrel—Fatigue—Hydroxyurea—head and neck cancer	0.00189	0.00443	CcSEcCtD
Levonorgestrel—Constipation—Hydroxyurea—head and neck cancer	0.00188	0.00439	CcSEcCtD
Levonorgestrel—Pain—Hydroxyurea—head and neck cancer	0.00188	0.00439	CcSEcCtD
Levonorgestrel—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00186	0.00523	CbGpPWpGaD
Levonorgestrel—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.00184	0.00518	CbGpPWpGaD
Levonorgestrel—Weight increased—Docetaxel—head and neck cancer	0.00183	0.00427	CcSEcCtD
Levonorgestrel—Weight decreased—Docetaxel—head and neck cancer	0.00181	0.00424	CcSEcCtD
Levonorgestrel—AR—lymph node—head and neck cancer	0.0018	0.00833	CbGeAlD
Levonorgestrel—Pneumonia—Docetaxel—head and neck cancer	0.0018	0.00421	CcSEcCtD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.0018	0.00504	CbGpPWpGaD
Levonorgestrel—Anaemia—Fluorouracil—head and neck cancer	0.00179	0.00419	CcSEcCtD
Levonorgestrel—Infestation NOS—Docetaxel—head and neck cancer	0.00179	0.00418	CcSEcCtD
Levonorgestrel—Infestation—Docetaxel—head and neck cancer	0.00179	0.00418	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00178	0.00498	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Vinblastine—head and neck cancer	0.00177	0.00415	CcSEcCtD
Levonorgestrel—ESR1—lymph node—head and neck cancer	0.00177	0.00818	CbGeAlD
Levonorgestrel—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00177	0.00495	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00176	0.00493	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00176	0.00493	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.00175	0.0049	CbGpPWpGaD
Levonorgestrel—Body temperature increased—Hydroxyurea—head and neck cancer	0.00174	0.00406	CcSEcCtD
Levonorgestrel—Asthenia—Vinblastine—head and neck cancer	0.00173	0.00404	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—NAT2—head and neck cancer	0.00167	0.00469	CbGpPWpGaD
Levonorgestrel—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00167	0.00467	CbGpPWpGaD
Levonorgestrel—Myalgia—Fluorouracil—head and neck cancer	0.00165	0.00386	CcSEcCtD
Levonorgestrel—Chest pain—Fluorouracil—head and neck cancer	0.00165	0.00386	CcSEcCtD
Levonorgestrel—Diarrhoea—Vinblastine—head and neck cancer	0.00165	0.00385	CcSEcCtD
Levonorgestrel—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.00163	0.00457	CbGpPWpGaD
Levonorgestrel—Discomfort—Fluorouracil—head and neck cancer	0.00163	0.00381	CcSEcCtD
Levonorgestrel—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00162	0.00455	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00162	0.00378	CcSEcCtD
Levonorgestrel—Haemoglobin—Docetaxel—head and neck cancer	0.00161	0.00377	CcSEcCtD
Levonorgestrel—Rhinitis—Docetaxel—head and neck cancer	0.00161	0.00376	CcSEcCtD
Levonorgestrel—Haemorrhage—Docetaxel—head and neck cancer	0.00161	0.00375	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.0016	0.00449	CbGpPWpGaD
Levonorgestrel—Hypoaesthesia—Docetaxel—head and neck cancer	0.0016	0.00374	CcSEcCtD
Levonorgestrel—Pharyngitis—Docetaxel—head and neck cancer	0.00159	0.00373	CcSEcCtD
Levonorgestrel—Dizziness—Vinblastine—head and neck cancer	0.00159	0.00372	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Docetaxel—head and neck cancer	0.00159	0.00371	CcSEcCtD
Levonorgestrel—Oedema—Fluorouracil—head and neck cancer	0.00158	0.0037	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Docetaxel—head and neck cancer	0.00158	0.00369	CcSEcCtD
Levonorgestrel—Asthenia—Hydroxyurea—head and neck cancer	0.00157	0.00368	CcSEcCtD
Levonorgestrel—Urethral disorder—Docetaxel—head and neck cancer	0.00157	0.00368	CcSEcCtD
Levonorgestrel—Infection—Fluorouracil—head and neck cancer	0.00157	0.00367	CcSEcCtD
Levonorgestrel—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00156	0.00438	CbGpPWpGaD
Levonorgestrel—Nervous system disorder—Fluorouracil—head and neck cancer	0.00155	0.00362	CcSEcCtD
Levonorgestrel—Visual impairment—Docetaxel—head and neck cancer	0.00155	0.00362	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.00154	0.00433	CbGpPWpGaD
Levonorgestrel—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00154	0.00432	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.00154	0.00431	CbGpPWpGaD
Levonorgestrel—Vomiting—Vinblastine—head and neck cancer	0.00153	0.00358	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00152	0.00427	CbGpPWpGaD
Levonorgestrel—Erythema multiforme—Docetaxel—head and neck cancer	0.00152	0.00355	CcSEcCtD
Levonorgestrel—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.00151	0.00425	CbGpPWpGaD
Levonorgestrel—Headache—Vinblastine—head and neck cancer	0.00151	0.00353	CcSEcCtD
Levonorgestrel—Anorexia—Fluorouracil—head and neck cancer	0.00151	0.00352	CcSEcCtD
Levonorgestrel—Diarrhoea—Hydroxyurea—head and neck cancer	0.0015	0.00351	CcSEcCtD
Levonorgestrel—Eye disorder—Docetaxel—head and neck cancer	0.0015	0.00351	CcSEcCtD
Levonorgestrel—Cardiac disorder—Docetaxel—head and neck cancer	0.00149	0.00348	CcSEcCtD
Levonorgestrel—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.00148	0.00415	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—DPYD—head and neck cancer	0.00147	0.00412	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00146	0.00408	CbGpPWpGaD
Levonorgestrel—Dizziness—Hydroxyurea—head and neck cancer	0.00145	0.0034	CcSEcCtD
Levonorgestrel—Immune system disorder—Docetaxel—head and neck cancer	0.00145	0.00339	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Docetaxel—head and neck cancer	0.00145	0.00338	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00144	0.00337	CcSEcCtD
Levonorgestrel—Arrhythmia—Docetaxel—head and neck cancer	0.00143	0.00335	CcSEcCtD
Levonorgestrel—Nausea—Vinblastine—head and neck cancer	0.00143	0.00334	CcSEcCtD
Levonorgestrel—Insomnia—Fluorouracil—head and neck cancer	0.00143	0.00334	CcSEcCtD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.00142	0.00399	CbGpPWpGaD
Levonorgestrel—Alopecia—Docetaxel—head and neck cancer	0.00142	0.00332	CcSEcCtD
Levonorgestrel—Dyspnoea—Fluorouracil—head and neck cancer	0.00141	0.0033	CcSEcCtD
Levonorgestrel—Mental disorder—Docetaxel—head and neck cancer	0.00141	0.00329	CcSEcCtD
Levonorgestrel—Somnolence—Fluorouracil—head and neck cancer	0.0014	0.00329	CcSEcCtD
Levonorgestrel—Erythema—Docetaxel—head and neck cancer	0.0014	0.00327	CcSEcCtD
Levonorgestrel—Malnutrition—Docetaxel—head and neck cancer	0.0014	0.00327	CcSEcCtD
Levonorgestrel—Vomiting—Hydroxyurea—head and neck cancer	0.0014	0.00326	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—YAP1—head and neck cancer	0.00139	0.00391	CbGpPWpGaD
Levonorgestrel—Dyspepsia—Fluorouracil—head and neck cancer	0.00139	0.00325	CcSEcCtD
Levonorgestrel—Rash—Hydroxyurea—head and neck cancer	0.00138	0.00324	CcSEcCtD
Levonorgestrel—Dermatitis—Hydroxyurea—head and neck cancer	0.00138	0.00323	CcSEcCtD
Levonorgestrel—Headache—Hydroxyurea—head and neck cancer	0.00138	0.00322	CcSEcCtD
Levonorgestrel—Decreased appetite—Fluorouracil—head and neck cancer	0.00137	0.00321	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00136	0.00319	CcSEcCtD
Levonorgestrel—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00136	0.00382	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.00135	0.0038	CbGpPWpGaD
Levonorgestrel—Back pain—Docetaxel—head and neck cancer	0.00135	0.00316	CcSEcCtD
Levonorgestrel—Pain—Fluorouracil—head and neck cancer	0.00135	0.00316	CcSEcCtD
Levonorgestrel—Muscle spasms—Docetaxel—head and neck cancer	0.00134	0.00314	CcSEcCtD
Levonorgestrel—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.00133	0.00373	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.00131	0.00368	CbGpPWpGaD
Levonorgestrel—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.00131	0.00367	CbGpPWpGaD
Levonorgestrel—Nausea—Hydroxyurea—head and neck cancer	0.0013	0.00305	CcSEcCtD
Levonorgestrel—Anaemia—Docetaxel—head and neck cancer	0.00129	0.00302	CcSEcCtD
Levonorgestrel—Urticaria—Fluorouracil—head and neck cancer	0.00126	0.00294	CcSEcCtD
Levonorgestrel—Syncope—Docetaxel—head and neck cancer	0.00125	0.00293	CcSEcCtD
Levonorgestrel—Body temperature increased—Fluorouracil—head and neck cancer	0.00125	0.00292	CcSEcCtD
Levonorgestrel—Palpitations—Docetaxel—head and neck cancer	0.00123	0.00289	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00123	0.00346	CbGpPWpGaD
Levonorgestrel—Loss of consciousness—Docetaxel—head and neck cancer	0.00123	0.00287	CcSEcCtD
Levonorgestrel—Cough—Docetaxel—head and neck cancer	0.00122	0.00285	CcSEcCtD
Levonorgestrel—Hypertension—Docetaxel—head and neck cancer	0.00121	0.00282	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.0012	0.00336	CbGpPWpGaD
Levonorgestrel—Chest pain—Docetaxel—head and neck cancer	0.00119	0.00278	CcSEcCtD
Levonorgestrel—Myalgia—Docetaxel—head and neck cancer	0.00119	0.00278	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00118	0.00276	CcSEcCtD
Levonorgestrel—Hypersensitivity—Fluorouracil—head and neck cancer	0.00116	0.00272	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.00115	0.00321	CbGpPWpGaD
Levonorgestrel—Oedema—Docetaxel—head and neck cancer	0.00114	0.00267	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00113	0.00318	CbGpPWpGaD
Levonorgestrel—Infection—Docetaxel—head and neck cancer	0.00113	0.00265	CcSEcCtD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00113	0.00316	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.00113	0.00316	CbGpPWpGaD
Levonorgestrel—Shock—Docetaxel—head and neck cancer	0.00112	0.00262	CcSEcCtD
Levonorgestrel—Nervous system disorder—Docetaxel—head and neck cancer	0.00112	0.00262	CcSEcCtD
Levonorgestrel—Pruritus—Fluorouracil—head and neck cancer	0.00112	0.00261	CcSEcCtD
Levonorgestrel—Skin disorder—Docetaxel—head and neck cancer	0.00111	0.00259	CcSEcCtD
Levonorgestrel—Anorexia—Docetaxel—head and neck cancer	0.00109	0.00254	CcSEcCtD
Levonorgestrel—Diarrhoea—Fluorouracil—head and neck cancer	0.00108	0.00253	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00108	0.00303	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00108	0.00302	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00106	0.00296	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.00105	0.00295	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	0.00105	0.00294	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00105	0.00293	CbGpPWpGaD
Levonorgestrel—Dizziness—Fluorouracil—head and neck cancer	0.00104	0.00244	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00104	0.00243	CcSEcCtD
Levonorgestrel—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00103	0.0029	CbGpPWpGaD
Levonorgestrel—Insomnia—Docetaxel—head and neck cancer	0.00103	0.00241	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.00103	0.00289	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.00103	0.00289	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00103	0.00288	CbGpPWpGaD
Levonorgestrel—Dyspnoea—Docetaxel—head and neck cancer	0.00102	0.00238	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.00102	0.00285	CbGpPWpGaD
Levonorgestrel—Somnolence—Docetaxel—head and neck cancer	0.00101	0.00237	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.00101	0.00283	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.00101	0.00282	CbGpPWpGaD
Levonorgestrel—Vomiting—Fluorouracil—head and neck cancer	0.001	0.00235	CcSEcCtD
Levonorgestrel—Dyspepsia—Docetaxel—head and neck cancer	0.001	0.00235	CcSEcCtD
Levonorgestrel—Rash—Fluorouracil—head and neck cancer	0.000996	0.00233	CcSEcCtD
Levonorgestrel—Dermatitis—Fluorouracil—head and neck cancer	0.000995	0.00233	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.000995	0.00279	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Docetaxel—head and neck cancer	0.000991	0.00232	CcSEcCtD
Levonorgestrel—Headache—Fluorouracil—head and neck cancer	0.00099	0.00232	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000985	0.0023	CcSEcCtD
Levonorgestrel—Fatigue—Docetaxel—head and neck cancer	0.000983	0.0023	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000982	0.00276	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000981	0.00275	CbGpPWpGaD
Levonorgestrel—Constipation—Docetaxel—head and neck cancer	0.000975	0.00228	CcSEcCtD
Levonorgestrel—Pain—Docetaxel—head and neck cancer	0.000975	0.00228	CcSEcCtD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.000955	0.00268	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.000949	0.00266	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000948	0.00266	CbGpPWpGaD
Levonorgestrel—Nausea—Fluorouracil—head and neck cancer	0.000939	0.0022	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000938	0.00263	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000936	0.00263	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000933	0.00218	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.000929	0.00261	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.000929	0.00261	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000925	0.00259	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000912	0.00256	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.000908	0.00255	CbGpPWpGaD
Levonorgestrel—Body temperature increased—Docetaxel—head and neck cancer	0.000902	0.00211	CcSEcCtD
Levonorgestrel—Abdominal pain—Docetaxel—head and neck cancer	0.000902	0.00211	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000884	0.00248	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—UROD—head and neck cancer	0.000875	0.00245	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000874	0.00245	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.000869	0.00244	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000866	0.00243	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Docetaxel—head and neck cancer	0.00084	0.00197	CcSEcCtD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000838	0.00235	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—TYMS—head and neck cancer	0.000836	0.00235	CbGpPWpGaD
Levonorgestrel—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000834	0.00234	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.000829	0.00233	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—GSTM1—head and neck cancer	0.000826	0.00232	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000825	0.00232	CbGpPWpGaD
Levonorgestrel—Asthenia—Docetaxel—head and neck cancer	0.000818	0.00191	CcSEcCtD
Levonorgestrel—Pruritus—Docetaxel—head and neck cancer	0.000807	0.00189	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000805	0.00226	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000803	0.00225	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.000802	0.00225	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000796	0.00223	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.000795	0.00223	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000792	0.00222	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—GPX1—head and neck cancer	0.000791	0.00222	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.000789	0.00221	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.000789	0.00221	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CYP1A1—head and neck cancer	0.000783	0.0022	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Docetaxel—head and neck cancer	0.00078	0.00183	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000775	0.00218	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000766	0.00215	CbGpPWpGaD
Levonorgestrel—Dizziness—Docetaxel—head and neck cancer	0.000754	0.00176	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000742	0.00208	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000729	0.00205	CbGpPWpGaD
Levonorgestrel—Vomiting—Docetaxel—head and neck cancer	0.000725	0.0017	CcSEcCtD
Levonorgestrel—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000723	0.00203	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000721	0.00202	CbGpPWpGaD
Levonorgestrel—Rash—Docetaxel—head and neck cancer	0.000719	0.00168	CcSEcCtD
Levonorgestrel—Dermatitis—Docetaxel—head and neck cancer	0.000718	0.00168	CcSEcCtD
Levonorgestrel—Headache—Docetaxel—head and neck cancer	0.000714	0.00167	CcSEcCtD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000712	0.002	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000706	0.00198	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000706	0.00198	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000691	0.00194	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000689	0.00193	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000679	0.0019	CbGpPWpGaD
Levonorgestrel—Nausea—Docetaxel—head and neck cancer	0.000677	0.00158	CcSEcCtD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000674	0.00189	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000665	0.00187	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000665	0.00187	CbGpPWpGaD
Levonorgestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000665	0.00187	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—RARB—head and neck cancer	0.000652	0.00183	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000647	0.00182	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000643	0.00181	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000632	0.00177	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000631	0.00177	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00062	0.00174	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000619	0.00174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000613	0.00172	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000611	0.00172	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000601	0.00169	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000597	0.00168	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000593	0.00166	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—YAP1—head and neck cancer	0.000593	0.00166	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000585	0.00164	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000585	0.00164	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000585	0.00164	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000572	0.00161	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000571	0.0016	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.000567	0.00159	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000559	0.00157	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000555	0.00156	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000551	0.00155	CbGpPWpGaD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000546	0.00153	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KISS1—head and neck cancer	0.000545	0.00153	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000541	0.00152	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000541	0.00152	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000531	0.00149	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000517	0.00145	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000517	0.00145	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000513	0.00144	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000512	0.00144	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.00051	0.00143	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.000501	0.0014	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000498	0.0014	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RARB—head and neck cancer	0.000497	0.00139	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000487	0.00137	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000486	0.00136	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000471	0.00132	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—head and neck cancer	0.000466	0.00131	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000465	0.00131	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000465	0.00131	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000463	0.0013	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000454	0.00127	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—YAP1—head and neck cancer	0.000452	0.00127	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GRP—head and neck cancer	0.000449	0.00126	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000448	0.00126	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000448	0.00126	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.00044	0.00123	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT6—head and neck cancer	0.000436	0.00122	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000436	0.00122	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000425	0.00119	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000423	0.00119	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000417	0.00117	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000417	0.00117	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000414	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000414	0.00116	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTEN—head and neck cancer	0.000406	0.00114	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000391	0.0011	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000389	0.00109	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000386	0.00108	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—YAP1—head and neck cancer	0.000386	0.00108	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000384	0.00108	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000383	0.00108	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RARB—head and neck cancer	0.000383	0.00107	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000382	0.00107	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000376	0.00106	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NAT2—head and neck cancer	0.000363	0.00102	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000363	0.00102	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.00036	0.00101	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.00035	0.000981	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—YAP1—head and neck cancer	0.000348	0.000976	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000345	0.000969	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000345	0.000968	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.000333	0.000934	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.00033	0.000926	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000326	0.000914	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.00032	0.000897	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000319	0.000894	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000318	0.000891	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000306	0.000859	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—YAP1—head and neck cancer	0.000302	0.000848	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000302	0.000847	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.0003	0.000841	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000295	0.000829	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.000294	0.000824	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.00029	0.000814	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00029	0.000813	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CA—head and neck cancer	0.000287	0.000804	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000286	0.000803	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH1—head and neck cancer	0.000267	0.00075	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000263	0.000739	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000256	0.000717	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UROD—head and neck cancer	0.000255	0.000716	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000245	0.000687	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—head and neck cancer	0.000234	0.000657	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000227	0.000637	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000226	0.000635	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH1—head and neck cancer	0.000204	0.000571	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000198	0.000556	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TYMS—head and neck cancer	0.000182	0.000509	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—head and neck cancer	0.000179	0.000503	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH1—head and neck cancer	0.000174	0.000488	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GPX1—head and neck cancer	0.000172	0.000482	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A1—head and neck cancer	0.00017	0.000477	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.000157	0.00044	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAPK3—head and neck cancer	0.000148	0.000415	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.00014	0.000392	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—head and neck cancer	0.00012	0.000335	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—head and neck cancer	0.000117	0.000327	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAPK3—head and neck cancer	0.000113	0.000316	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTEN—head and neck cancer	0.000113	0.000316	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAT2—head and neck cancer	0.000106	0.000297	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000102	0.000286	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—head and neck cancer	0.000102	0.000285	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—head and neck cancer	0.000101	0.000284	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—head and neck cancer	0.000101	0.000282	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—head and neck cancer	9.97e-05	0.00028	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK3—head and neck cancer	9.61e-05	0.00027	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DPYD—head and neck cancer	9.3e-05	0.000261	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK1—head and neck cancer	9.15e-05	0.000257	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—head and neck cancer	9.15e-05	0.000257	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—YAP1—head and neck cancer	8.82e-05	0.000247	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTEN—head and neck cancer	8.82e-05	0.000247	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAPK3—head and neck cancer	8.68e-05	0.000243	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—head and neck cancer	7.94e-05	0.000223	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—head and neck cancer	7.68e-05	0.000215	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—head and neck cancer	7.6e-05	0.000213	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HRAS—head and neck cancer	7.34e-05	0.000206	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—head and neck cancer	7.02e-05	0.000197	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—head and neck cancer	6.84e-05	0.000192	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTEN—head and neck cancer	6.6e-05	0.000185	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—head and neck cancer	6.48e-05	0.000182	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—head and neck cancer	6.22e-05	0.000175	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—head and neck cancer	5.96e-05	0.000167	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—head and neck cancer	5.91e-05	0.000166	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—head and neck cancer	5.85e-05	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK3—head and neck cancer	5.64e-05	0.000158	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK1—head and neck cancer	5.37e-05	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—head and neck cancer	5.37e-05	0.000151	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TYMS—head and neck cancer	5.3e-05	0.000149	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—head and neck cancer	5.24e-05	0.000147	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—head and neck cancer	5.08e-05	0.000143	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX1—head and neck cancer	5.01e-05	0.000141	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.96e-05	0.000139	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	4.66e-05	0.000131	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—head and neck cancer	4.51e-05	0.000126	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRAS—head and neck cancer	4.31e-05	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—head and neck cancer	3.81e-05	0.000107	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.95e-05	8.28e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTEN—head and neck cancer	2.57e-05	7.22e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.82e-05	5.1e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—head and neck cancer	1.48e-05	4.16e-05	CbGpPWpGaD
